pentazocine has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Börgel, F; Catapano, CV; Civenni, G; Friedland, K; Holtschulte, C; Humpf, HU; Kopp, N; Laurini, E; Lehmkuhl, K; Pricl, S; Schepmann, D; Wünsch, B | 1 |
| Bowen, WD; John, CS; Vilner, BJ | 1 |
| Bowen, WD; Geyer, BC; John, CS; Moody, T; Vilner, BJ | 1 |
3 other study(ies) available for pentazocine and Cancer of Prostate
| Article | Year |
|---|---|
Novel σ
Topics: Amination; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclohexanes; Humans; Male; Mice; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor; Structure-Activity Relationship | 2021 |
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Topics: Adenocarcinoma; Animals; Binding, Competitive; Breast Neoplasms; Carcinoma, Ductal, Breast; Glioblastoma; Guanidines; Haloperidol; Humans; Leukemia; Lung Neoplasms; Male; Melanoma; Mice; Neuroblastoma; Pentazocine; Prostatic Neoplasms; Receptors, sigma; Tumor Cells, Cultured | 1995 |
Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
Topics: Animals; Antineoplastic Agents; Benzamides; Binding, Competitive; Brain; Cell Membrane; Guinea Pigs; Humans; Iodine Radioisotopes; Levallorphan; Liver; Male; Mice; Mice, Nude; Pentazocine; Piperidines; Prostatic Neoplasms; Rats; Receptors, sigma; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |